A Prospective Treatment Option for Lysosomal Storage Diseases: CRISPR/Cas9 Gene Editing Technology for Mutation Correction in Induced Pluripotent Stem Cells

Ease of design, relatively low cost and a multitude of gene-altering capabilities have all led to the adoption of the sophisticated and yet simple gene editing system: clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9). The CRISPR/Cas9 system holds pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Chloe L., Choy, Francis Y. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5456334/
https://www.ncbi.nlm.nih.gov/pubmed/28933359
http://dx.doi.org/10.3390/diseases5010006

Ejemplares similares

Ejemplares similares